SwissHealth Ventures: digital, innovative, personal.
SwissHealth Ventures invests in start-ups whose ideas set the course for a high quality, cost-effective healthcare system.Our focus
SwissHealth Ventures AG is a member of the CSS Group, Switzerland's leading health insurer. We are the ideal health partner for ambitious start-ups in the field of digital health.
With the support of Redstone, an experienced venture capital partner, our industry expertise facilitates agile, sustainable growth.
We invest in start-ups that are seeking to create synergies with the CSS Group and have new digital technologies that move healthcare forward. Targeted investments support our aim of helping people to stay healthy, become healthy or live with illness. We also focus on digital solutions that generate an immediate efficiency gain for health insurers in their core business.
More efficiency thanks to new technologies
Lifestyle and wellness innovations
Digitally supported recovery
Support for chronic illnesses
Does your start-up fit our investment criteria? And are there potential synergies with the CSS Group? Then we look forward to hearing from you.
OnlineDoctor allows skin problems to be assessed quickly and cost-effectively, no matter where you are, by an independent specialist licensed in Switzerland. Patients receive a specialist assessment, including a recommendation for action, via a web-based platform within 48 hours. SwissHealth Ventures invested in this Swiss telemedicine start-up in 2020 as lead investor in the series A round (which raised a total of around CHF 5.5 million in funding from all investors).
CSS has already made this service a fixed part of its offering, where it is known as the «online skin check». The uncomplicated skin check by Swiss dermatologists contributes to digital integrated care.
Pregnolia has developed a device that supports the diagnosis of premature birth. It enables gynaecologists to measure cervical tissue stiffness more precisely and thus make a better assessment of the risk of premature birth. SwissHealth Ventures invested in the ETH spin-off in 2020 as lead investor in the series A round (which raised a total of CHF 4.2 million in funding from all investors).
SwissHealth Ventures believes in the success of the Pregnolia measurement system and its ability to provide great reassurance to professionals and pregnant women. We also believe that this method will reduce healthcare costs in the long term.